Q&A with Claire Lever, discussing her new role supporting cardio metabolic therapies

Congratulations on your new position of Associate Director, Global Business Development Cardio Metabolic Solutions! Can you tell us a bit about your new role?

I will be instrumental in identifying new market opportunities, forging strategic partnerships, and driving the commercial success of a diverse and evolving portfolio of products. Woodley Trial Solutions are experts in Continuous Glucose Monitoring (CGM) systems, Blood Glucose Monitoring (BGM) devices, Ketone Monitoring (BKM) solutions, insulin delivery technologies such as pumps and smart pens, alongside digital health tools that support data-driven, personalised diabetes and other metabolic care.

How much pride do you have in your role, knowing that you are making a positive impact in supporting new treatments for Cardiometabolic diseases?

Therapies such as GLP-1s for obesity and diabetes, along with advances in cardiovascular care and emerging treatments for conditions like MASLD/MASH and CKD, are more than medical progress, they’re transformative for the lives of millions, so I'm really proud to play a small role in supporting this research. My focus areas guide our strategic partnerships, ensuring that our work contributes meaningfully to the future of cardiometabolic care.

Some of the specific areas I'm excited to support include:

• Metabolic Syndromes
• Cardiovascular Disease (CVD)
• Non-Alcoholic Fatty Liver Disease (MASLD/MASH)
• Chronic Kidney Disease (CKD)
• Endocrine & Rare Metabolic Disorders
• Obesity & Weight Management (including GLP-1 therapies)

If you need support with metabolic monitoring devices supply, please get in touch!

Please tell us about your background with Woodley Trial Solutions and how this can make a big impact with supporting cardio metabolic studies?

My background, firstly as Key Account Manager and then leading the Account Management team at Woodley Trial Solutions has given me a strong foundation for success in the cardiometabolic space. Managing global partnerships for over 10 years in the clinical trials industry has equipped me with operational insights, product expertise, and a patient-centric mindset - essential for identifying new opportunities and driving impactful solutions in cardiometabolic health.

Woodley Trial Solutions have supported several metabolic studies for a number of years now with supply of metabolic devices such as Dexcom G7 CGM, Abbott FreeStyle Optium Neo and Roche Accu-Chek Guide. I've developed a great understanding of the products, which studies they are suitable for and where they are regulated for use. I can help guide you and take that stress away when you are planning your study protocol.

How can people get in touch to discuss how you can help support their cardio metabolic study with device supply and additional services?

Business development isn’t just growth, it’s about delivering innovative, reliable, and patient-centric solutions. Every partnership we form and every solution we deliver accelerates trial success, enhances data quality, and moves us closer to a world where people living with cardiometabolic disorders can enjoy healthier, more empowered lives.

If you’re working in this space, or passionate about transforming cardiometabolic care I’d love to connect, collaborate, and learn from your journey. 

You can contact Claire Lever to discuss our supply of metabolic monitoring devices via below channels. 

Tel: +44 (0)1204 471 303
Email: clairel@woodleytrialsolutions.com 
LinkedIn: Claire Lever
Online: Metabolic monitoring devices

Claire is also attending the 17th Annual Outsourcing in Clinical Trials New England 2025 conference in Boston on 15-16 October. If you are attending, please visit us at booth 28 to find out more about our metabolic monitoring device supply solutions.